Literature DB >> 21562402

The relationship between hospital lung cancer resection volume and patient mortality risk.

Benjamin D Kozower1, George J Stukenborg.   

Abstract

OBJECTIVE: To evaluate the volume-outcome relationship after lung cancer resection using 3 alternative measures of the effect of volume. SUMMARY BACKGROUND DATA: Many studies of lung cancer resection indicate that hospital volume predicts mortality. However, controversy exists regarding the strength and validity of this association. Because thresholds of procedure volume are used to recommend the regionalization of care, investigation of the validity of the volume-outcome relationship is necessary.
METHODS: Lung cancer resection patients were identified in the 2007 Nationwide Inpatient Sample. Hospital volume was measured using 3 different methods: as a continuous linear function, as a nonlinear function using restricted cubic splines, and as the frequently used method of quintile categories. The statistical significance of the relationship between hospital volume and mortality risk was assessed, adjusted for patient age, comorbid disease, and for correlated events within hospitals.
RESULTS: Forty thousand four hundred and sixty lung cancer resection patients from 436 hospitals were identified. All 3 models demonstrated excellent performance characteristics (C index = 0.92, Nagelkerke R = 0.37). No significant association was demonstrated between hospital procedure volume and in-hospital mortality when measured as a linear or nonlinear function using splines. However, a statistically significant relationship was found for volume categorized into quintiles, although its relative contribution to the predictive capacity of the model was very small (likelihood ratio = 2.55, P = 0.04).
CONCLUSIONS: The apparent impact of hospital lung cancer resection volume on mortality is dependent on how volume is defined and entered into the regression equation. Hospital lung cancer resection volume is not a predictor of mortality and should not be used as a proxy measure for surgical quality.

Entities:  

Mesh:

Year:  2011        PMID: 21562402     DOI: 10.1097/SLA.0b013e31821d4bdd

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

Review 1.  What is quality, and can we define it in lung cancer?-the case for quality improvement.

Authors:  Farhood Farjah; Frank C Detterbeck
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  The challenge of achieving 1% operative mortality for coronary artery bypass grafting: a multi-institution Society of Thoracic Surgeons Database analysis.

Authors:  Damien J LaPar; Giovanni Filardo; Ivan K Crosby; Alan M Speir; Jeffrey B Rich; Irving L Kron; Gorav Ailawadi
Journal:  J Thorac Cardiovasc Surg       Date:  2014-07-24       Impact factor: 5.209

3.  Risk-Adjusted Margin Positivity Rate as a Surgical Quality Metric for Non-Small Cell Lung Cancer.

Authors:  Chun Chieh Lin; Matthew P Smeltzer; Ahmedin Jemal; Raymond U Osarogiagbon
Journal:  Ann Thorac Surg       Date:  2017-07-12       Impact factor: 4.330

4.  Postoperative mortality is an inadequate quality indicator for lung cancer resection.

Authors:  Yinin Hu; Timothy L McMurry; Kristen M Wells; James M Isbell; George J Stukenborg; Benjamin D Kozower
Journal:  Ann Thorac Surg       Date:  2014-01-28       Impact factor: 4.330

5.  Socioeconomic risk factors for long-term mortality after pulmonary resection for lung cancer: an analysis of more than 90,000 patients from the National Cancer Data Base.

Authors:  Onkar V Khullar; Theresa Gillespie; Dana C Nickleach; Yuan Liu; Kristin Higgins; Suresh Ramalingam; Joseph Lipscomb; Felix G Fernandez
Journal:  J Am Coll Surg       Date:  2014-10-27       Impact factor: 6.113

6.  Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer.

Authors:  Anthony W Kim; Frank C Detterbeck; Daniel J Boffa; Roy H Decker; Pamela R Soulos; Laura D Cramer; Cary P Gross
Journal:  Ann Thorac Surg       Date:  2012-07-25       Impact factor: 4.330

Review 7.  Lung cancer surgery: an up to date.

Authors:  Nikolaos Baltayiannis; Michail Chandrinos; Dimitrios Anagnostopoulos; Paul Zarogoulidis; Kosmas Tsakiridis; Andreas Mpakas; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

8.  Type and case volume of health care facility influences survival and surgery selection in cases with early-stage non-small cell lung cancer.

Authors:  Shidan Wang; Sunny Lai; Mitchell S von Itzstein; Lin Yang; Donghan M Yang; Xiaowei Zhan; Guanghua Xiao; Ethan A Halm; David E Gerber; Yang Xie
Journal:  Cancer       Date:  2019-09-10       Impact factor: 6.860

9.  Surgery in high-volume hospitals not commission on cancer accreditation leads to increased cancer-specific survival for early-stage lung cancer.

Authors:  Elizabeth A David; David T Cooke; Yingjia Chen; Andrew Perry; Robert J Canter; Rosemary Cress
Journal:  Am J Surg       Date:  2015-06-27       Impact factor: 3.125

10.  Is an activity volume threshold really realistic for lung cancer resection?

Authors:  Alain Bernard; Jonathan Cottenet; Anne-Sophie Mariet; Catherine Quantin; Pierre-Benoit Pagès
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.